Ilse J. Hoogsteen

996 total citations
16 papers, 781 citations indexed

About

Ilse J. Hoogsteen is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Ilse J. Hoogsteen has authored 16 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Ilse J. Hoogsteen's work include Cancer, Hypoxia, and Metabolism (10 papers), Head and Neck Cancer Studies (4 papers) and Erythropoietin and Anemia Treatment (3 papers). Ilse J. Hoogsteen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Head and Neck Cancer Studies (4 papers) and Erythropoietin and Anemia Treatment (3 papers). Ilse J. Hoogsteen collaborates with scholars based in Netherlands and United States. Ilse J. Hoogsteen's co-authors include Johannes H.A.M. Kaanders, Albert J. van der Kogel, Henri A. M. Marres, Johan Bussink, Paul N. Span, Monique M. Nijkamp, Paul F.J.W. Rijken, Saskia E. Rademakers, Chris H.J. Terhaard and Piet van den Ende and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Ilse J. Hoogsteen

16 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilse J. Hoogsteen Netherlands 15 428 337 217 144 108 16 781
Justine Y. Bruce United States 16 175 0.4× 413 1.2× 329 1.5× 275 1.9× 129 1.2× 73 955
Rumi Murata Japan 18 356 0.8× 313 0.9× 175 0.8× 349 2.4× 311 2.9× 33 966
Eamonn P. Dunphy United States 12 205 0.5× 220 0.7× 365 1.7× 172 1.2× 142 1.3× 18 799
Maud H. W. Starmans Netherlands 15 371 0.9× 504 1.5× 215 1.0× 309 2.1× 337 3.1× 26 1.1k
Mary-Claire Kavanagh Canada 7 528 1.2× 226 0.7× 133 0.6× 159 1.1× 272 2.5× 9 867
A.C. Begg Netherlands 12 217 0.5× 178 0.5× 215 1.0× 218 1.5× 144 1.3× 28 751
Dawn Carnell United Kingdom 8 175 0.4× 150 0.4× 73 0.3× 169 1.2× 164 1.5× 15 533
Weikai Xiao China 18 473 1.1× 425 1.3× 477 2.2× 265 1.8× 73 0.7× 37 1.1k
David Molkentine United States 16 125 0.3× 371 1.1× 357 1.6× 186 1.3× 67 0.6× 30 708
Andrea Pirzkall United States 16 446 1.0× 305 0.9× 794 3.7× 479 3.3× 276 2.6× 31 1.2k

Countries citing papers authored by Ilse J. Hoogsteen

Since Specialization
Citations

This map shows the geographic impact of Ilse J. Hoogsteen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse J. Hoogsteen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse J. Hoogsteen more than expected).

Fields of papers citing papers by Ilse J. Hoogsteen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse J. Hoogsteen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse J. Hoogsteen. The network helps show where Ilse J. Hoogsteen may publish in the future.

Co-authorship network of co-authors of Ilse J. Hoogsteen

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse J. Hoogsteen. A scholar is included among the top collaborators of Ilse J. Hoogsteen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse J. Hoogsteen. Ilse J. Hoogsteen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Janssens, Geert O., Saskia E. Rademakers, Chris H.J. Terhaard, et al.. (2014). Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer. Clinical Cancer Research. 20(5). 1345–1354. 29 indexed citations
2.
Rademakers, Saskia E., Ilse J. Hoogsteen, Paul F.J.W. Rijken, et al.. (2013). Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial. Radiotherapy and Oncology. 108(3). 517–522. 21 indexed citations
3.
Rademakers, Saskia E., Ilse J. Hoogsteen, Paul F.J.W. Rijken, et al.. (2013). Prognostic value of the proliferation marker Ki‐67 in laryngeal carcinoma: Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase III randomized trial. Head & Neck. 37(2). 171–176. 19 indexed citations
4.
Hoogsteen, Ilse J., Henri A. M. Marres, Franciscus J.A. van den Hoogen, et al.. (2012). Expression of EGFR Under Tumor Hypoxia: Identification of a Subpopulation of Tumor Cells Responsible for Aggressiveness and Treatment Resistance. International Journal of Radiation Oncology*Biology*Physics. 84(3). 807–814. 23 indexed citations
5.
Janssens, Geert O., Saskia E. Rademakers, Chris H.J. Terhaard, et al.. (2012). Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial. Journal of Clinical Oncology. 30(15). 1777–1783. 187 indexed citations
6.
Nijkamp, Monique M., Paul N. Span, Ilse J. Hoogsteen, et al.. (2011). Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiotherapy and Oncology. 99(3). 344–348. 155 indexed citations
7.
Nijkamp, Monique M., Ilse J. Hoogsteen, Paul N. Span, et al.. (2011). Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma. Radiotherapy and Oncology. 101(1). 165–170. 24 indexed citations
8.
Hoogsteen, Ilse J., Jasper Lok, Henri A. M. Marres, et al.. (2009). Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. European Journal of Cancer. 45(16). 2906–2914. 30 indexed citations
9.
Wijffels, Karien I.E.M., Ilse J. Hoogsteen, Jasper Lok, et al.. (2008). No Detectable Hypoxia in Malignant Salivary Gland Tumors: Preliminary Results. International Journal of Radiation Oncology*Biology*Physics. 73(5). 1319–1325. 8 indexed citations
10.
Hoogsteen, Ilse J., Henri A. M. Marres, A.J. van der Kogel, & Johannes H.A.M. Kaanders. (2007). The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments. Clinical Oncology. 19(6). 385–396. 66 indexed citations
11.
Hoogsteen, Ilse J., Henri A. M. Marres, Johan Bussink, Albert J. van der Kogel, & Johannes H.A.M. Kaanders. (2007). Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A review. Head & Neck. 29(6). 591–604. 83 indexed citations
12.
Hoogsteen, Ilse J., Wenny J.M. Peeters, Henri A. M. Marres, et al.. (2005). Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas. Radiotherapy and Oncology. 76(2). 213–218. 17 indexed citations
13.
Hoogsteen, Ilse J., L.A.M. Pop, Henri A. M. Marres, et al.. (2005). Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology*Biology*Physics. 64(1). 83–89. 18 indexed citations
14.
Hoogsteen, Ilse J., Henri A. M. Marres, Karien I.E.M. Wijffels, et al.. (2005). Colocalization of Carbonic Anhydrase 9 Expression and Cell Proliferation in Human Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 11(1). 97–106. 66 indexed citations
15.
Hoogsteen, Ilse J., Hennie M.M. Schlüper, Marc Maliepaard, et al.. (2002). Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity. British Journal of Cancer. 87(6). 665–672. 21 indexed citations
16.
Boven, Epie, et al.. (2000). New Analogues of Camptothecins: Activity and Resistance. Annals of the New York Academy of Sciences. 922(1). 175–177. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justine Y. Bruce Breakdown of academic impact, for papers by Rumi Murata Breakdown of academic impact, for papers by Eamonn P. Dunphy Breakdown of academic impact, for papers by Maud H. W. Starmans Breakdown of academic impact, for papers by Mary-Claire Kavanagh Breakdown of academic impact, for papers by A.C. Begg Breakdown of academic impact, for papers by Dawn Carnell Breakdown of academic impact, for papers by Weikai Xiao Breakdown of academic impact, for papers by David Molkentine Breakdown of academic impact, for papers by Andrea Pirzkall
Rankless by CCL
2026